To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene APOLD1andDDX47TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
555 representative clones for gene APOLD1andDDX47 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK127712   .a 1 to 2375 1 to 2375 exact tiling clone, available from FLJ,   2375/2375
(100 %)
2 diff
(100.0 %id)
DA750758   .a 2 to 538 2 to 538   capped   537/537
(100 %)
2 diff
(99.7 %id)
BJ990926 hepatoblastoma .a 559 to 1138 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
BG707073 brain, hypothalamus .a 560 to 1406 1 to 843       843/851
(99 %)
12 diff
(98.6 %id)
BI601530 brain, hypothalamus .a 560 to 1455 1 to 896       894/945
(94 %)
27 diff
(97.2 %id)
AL136666 brain .a 565 to 2375 5 to 1815 exact available from DKFZ, AAA   1811/1811
(100 %)
2 diff
(99.9 %id)
AL697892 human skeletal muscle .a 565 to 1312 1 to 750       750/750
(100 %)
4 diff
(99.5 %id)
DA538407 Kidney .a 565 to 1148 2 to 582   capped   581/581
(100 %)
3 diff
(99.5 %id)
TI_45215379   .a 565 to 1455 91 to 981       889/1030
(86 %)
28 diff
(97.3 %id)
NM_016355.3   .a 565 to 2375 1 to 1811 exact RefSeq, AAA   1811/1811
(100 %)
0 diff
(100 %id)
BP332638 renal proximal tubule .a 565 to 1146 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DA145308 amygdala .a 566 to 1137 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA169773 amygdala .a 566 to 1133 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA250135 caudate nucleus .a 566 to 1129 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA251759 caudate nucleus .a 566 to 1146 2 to 582   capped   581/581
(100 %)
3 diff
(99.5 %id)
DA376442 thalamus .a 566 to 1114 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
AL549874 placenta, Placenta Cot 25-normalized .a 566 to 1514 1 to 947   fully sequenced,   947/947
(100 %)
6 diff
(99.4 %id)
DA614837   .a 566 to 1137 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA616173   .a 566 to 1136 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA653748   .a 566 to 1115 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA679457   .a 566 to 1144 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA716893   .a 566 to 1107 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA957866 Spleen .a 566 to 1120 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BP342916 stomach mucosa .a 566 to 1156 1 to 591       591/591
(100 %)
3 diff
(99.5 %id)
BP343317 stomach mucosa .a 566 to 1144 1 to 579       579/579
(100 %)
3 diff
(99.5 %id)
DB013111 esophageal, tumor tissue .a 566 to 1142 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DB037744 testis .a 566 to 1139 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DB199385 trachea .a 566 to 1135 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
CR623990 Placenta Cot 25-normalized .a 567 to 2362 1 to 1796 exact     1796/1796
(100 %)
0 diff
(100 %id)
DB462707 testis .a 567 to 1057 1 to 491       491/491
(100 %)
0 diff
(100 %id)
BP235810 coronary artery .a 567 to 1149 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP336316 coronary artery .a 567 to 1170 1 to 604       604/604
(100 %)
5 diff
(99.2 %id)
DB019446 esophageal, tumor tissue .a 567 to 1119 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB192558 ovary, tumor tissue .a 567 to 1138 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BM923212 pooled colon, kidney, stomach .a 571 to 1553 12 to 1002       991/1028
(96 %)
26 diff
(97.5 %id)
DA960418 Spleen .a 572 to 1126 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB466288 hippocampus .a 573 to 1005 1 to 433       433/433
(100 %)
0 diff
(100 %id)
CX785535 human embryonic stem cells .a 573 to 1355 1 to 783       783/783
(100 %)
0 diff
(100 %id)
DA569774 whole embryo, mainly head .a 574 to 1478 2 to 905   capped   904/904
(100 %)
11 diff
(98.8 %id)
DA276373 corpus callosum .a 576 to 1142 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
BI755974 brain .a 576 to 1416 1 to 842       842/842
(100 %)
12 diff
(98.6 %id)
BM450225 melanotic melanoma, skin .a 576 to 1552 1 to 977       977/1035
(94 %)
9 diff
(99.2 %id)
BF795842 lymph, lymphoma, cell line .a 577 to 1329 1 to 752       752/1060
(70 %)
24 diff
(97.8 %id)
BI759834 pooled colon, kidney, stomach .a 577 to 1376 1 to 804       804/805
(99 %)
7 diff
(99.2 %id)
CB962796 Blood vessels - aorta, basilar and artery .a 577 to 1327 1 to 767       765/770
(99 %)
28 diff
(96.4 %id)
AV718217 hypothalamus .a 578 to 1292 1 to 713       713/713
(100 %)
4 diff
(99.5 %id)
BX505234   .a 579 to 1441 1 to 865       865/873
(99 %)
4 diff
(99.6 %id)
CX164081 human embryonic stem cells differentiated toan early endodermal cell type .a 579 to 1466 1 to 889       889/889
(100 %)
2 diff
(99.8 %id)
AK054574   .a 580 to 2375 1 to 1796 I55V available from FLJ,   1796/1796
(100 %)
2 diff
(99.9 %id)
BP283090 bone marrow .a 580 to 1166 1 to 587       587/587
(100 %)
2 diff
(99.7 %id)
BP283113 bone marrow .a 580 to 1161 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
AU280694   .a 580 to 1136 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BP356059   .a 580 to 1160 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BP365083 lung .a 580 to 1163 1 to 583       583/583
(100 %)
5 diff
(99.2 %id)
CN407111 embryonic stem cells, DMSO-treated H9 cellline .a 581 to 1149 9 to 577       569/577
(98 %)
6 diff
(99.0 %id)
BX416339 neuroblastoma .a 581 to 1432 1 to 852       852/852
(100 %)
4 diff
(99.6 %id)
DA542728   .a 581 to 1374 2 to 794   capped   793/830
(95 %)
8 diff
(99.1 %id)
DA752097   .a 581 to 1157 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DB016562 esophageal, tumor tissue .a 581 to 1150 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB245018 uterus, tumor tissue .a 581 to 1144 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB258682 uterus .a 581 to 1145 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BM456149 lymph, lymphoma, cell line .a 582 to 1337 1 to 758       758/880
(86 %)
5 diff
(99.5 %id)
BC068009 Eye, retinoblastoma .a 583 to 2375 1 to 1793 exact available from MGC, AAA   1793/1793
(100 %)
0 diff
(100 %id)
CR621488 Placenta Cot 25-normalized .a 583 to 2338 1 to 1756 exact     1756/1756
(100 %)
0 diff
(100 %id)
AL547585 placenta, Placenta Cot 25-normalized .a 583 to 1425 1 to 846   fully sequenced,   843/843
(100 %)
8 diff
(99.1 %id)
CX784229 human embryonic stem cells .a 583 to 1214 1 to 632       632/632
(100 %)
0 diff
(100 %id)
DB168170 kidney, tumor tissue .a 583 to 1181 2 to 600   capped   599/599
(100 %)
1 diff
(99.9 %id)
BF794814 lymph, lymphoma, cell line .a 584 to 1430 15 to 867       853/887
(96 %)
46 diff
(94.9 %id)
BU193018 eye, retinoblastoma .a 584 to 1470 1 to 889       889/889
(100 %)
6 diff
(99.4 %id)
CB159622 Liver .a 584 to 1128 1 to 545       545/545
(100 %)
0 diff
(100 %id)
BG335418 choriocarcinoma, placenta .a 585 to 1208 1 to 628       628/927
(67 %)
13 diff
(98.6 %id)
CN407107 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 586 to 1138 1 to 553       553/553
(100 %)
0 diff
(100 %id)
AJ276704 cervical epithelial .a 587 to 2375 1 to 1789 A313E R314S AAA   1789/1789
(100 %)
4 diff
(99.8 %id)
BX441684 brain, fetal brain .a 590 to 1686 1 to 1092       1092/1092
(100 %)
12 diff
(99.0 %id)
BX421904 T cells (Jurkat cell line) .a 590 to 1621 1 to 1028       1028/1028
(100 %)
17 diff
(98.4 %id)
AL514848 neuroblastoma, placenta .a 591 to 1512 1 to 922       922/922
(100 %)
1 diff
(99.9 %id)
CN407103 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 591 to 1331 1 to 741       741/741
(100 %)
0 diff
(100 %id)
BI755706 brain .a 591 to 1456 1 to 870       870/870
(100 %)
14 diff
(98.4 %id)
TI_57217124   .a 591 to 1456 37 to 906       870/906
(96 %)
20 diff
(97.8 %id)
CN407114 embryonic stem cells, DMSO-treated H9 cellline .a 592 to 1366 9 to 783       775/783
(98 %)
0 diff
(100 %id)
CR619384 Placenta Cot 25-normalized .a 592 to 2325 1 to 1734       1734/1734
(100 %)
0 diff
(100 %id)
BX324797 Placenta Cot 25-normalized .a 592 to 1686 1 to 1090       1090/1090
(100 %)
11 diff
(99.0 %id)
AL554256 placenta, Placenta Cot 25-normalized .a 592 to 1483 1 to 892   fully sequenced,   892/892
(100 %)
2 diff
(99.8 %id)
BI760833 pooled colon, kidney, stomach .a 594 to 1337 1 to 744       744/746
(99 %)
7 diff
(99.1 %id)
AK225144 cerebellum .a 595 to 2375 1 to 1781   AAA   1781/1781
(100 %)
3 diff
(99.9 %id)
BP210607 cerebellum .a 595 to 1179 1 to 585       585/585
(100 %)
4 diff
(99.4 %id)
BQ421737 embryonal carcinoma, cell line, testis .a 595 to 1488 1 to 894       894/902
(99 %)
11 diff
(98.8 %id)
BQ230249 embryonal carcinoma, cell line, testis .a 595 to 1324 1 to 734       734/887
(82 %)
6 diff
(99.4 %id)
CN407105 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 596 to 1146 1 to 551       551/551
(100 %)
0 diff
(100 %id)
BE734439 choriocarcinoma, placenta .a 596 to 1446 1 to 857       857/1070
(80 %)
32 diff
(97.1 %id)
CR977142 T-Lymphocytes .a 596 to 1213 1 to 618       618/618
(100 %)
0 diff
(100 %id)
CR986671 T-Lymphocytes .a 596 to 1539 1 to 944       944/944
(100 %)
4 diff
(99.6 %id)
BE887643 leiomyosarcoma, uterus .a 597 to 1142 1 to 546       546/546
(100 %)
0 diff
(100 %id)
BG337738 leiomyosarcoma cell line, uterus .a 597 to 1424 1 to 817       817/878
(93 %)
25 diff
(97.2 %id)
BI917633 brain .a 597 to 1439 1 to 842       842/870
(96 %)
25 diff
(97.2 %id)
DR159627 human embryonic stem cells differentiated toan early endodermal cell type .a 597 to 1398 1 to 802       802/802
(100 %)
0 diff
(100 %id)
CV572672 cornea, eye .a 597 to 1231 1 to 635       635/635
(100 %)
0 diff
(100 %id)
CR599748 placenta .a 598 to 2103 1 to 1506       1506/1506
(100 %)
0 diff
(100 %id)
CR613162 Placenta Cot 25-normalized .a 598 to 2352 1 to 1755       1755/1755
(100 %)
0 diff
(100 %id)
CR620828 Placenta Cot 25-normalized .a 598 to 2325 1 to 1728       1728/1728
(100 %)
0 diff
(100 %id)
AL546499 placenta, Placenta Cot 25-normalized .a 598 to 1526 1 to 927   fully sequenced,   927/927
(100 %)
0 diff
(100 %id)
AL553318 placenta, Placenta Cot 25-normalized .a 598 to 1488 1 to 892       892/1025
(87 %)
3 diff
(99.8 %id)
BI910515 leukocyte .a 598 to 1304 1 to 717       717/916
(78 %)
15 diff
(98.4 %id)
BQ223267 large cell carcinoma, lung .a 599 to 1488 1 to 890       890/930
(95 %)
8 diff
(99.2 %id)
BU849982 ovary, teratocarcinoma, cell line .a 600 to 1488 1 to 888       888/906
(98 %)
8 diff
(99.2 %id)
CR994791 T-Lymphocytes .a 600 to 1171 1 to 572       572/572
(100 %)
5 diff
(99.2 %id)
BC009379 Brain, neuroblastoma .a 602 to 2375 1 to 1774   available from MGC, AAA   1774/1774
(100 %)
0 diff
(100 %id)
BG330798 large cell carcinoma, lung .a 602 to 1421 1 to 817       817/912
(89 %)
29 diff
(96.9 %id)
BE884317 leiomyosarcoma, uterus .a 603 to 1296 1 to 695       695/1001
(69 %)
13 diff
(98.8 %id)
CB132394 Liver .a 605 to 1212 1 to 608       608/608
(100 %)
0 diff
(100 %id)
CR982090 T-Lymphocytes .a 605 to 1525 1 to 927       927/927
(100 %)
6 diff
(99.4 %id)
AK222940 Kidney .a 606 to 2375 1 to 1770   AAA   1770/1770
(100 %)
4 diff
(99.8 %id)
BQ420419 embryonal carcinoma, cell line, testis .a 606 to 1412 1 to 812       812/902
(90 %)
11 diff
(98.8 %id)
BP374975 umbilical cord .a 608 to 1189 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA476423   .a 609 to 1173 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA645373   .a 609 to 1196 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
TI_154137471   .a 614 to 1297 33 to 725       693/960
(72 %)
26 diff
(97.3 %id)
EF036507   .a 618 to 1166 1 to 549       549/549
(100 %)
0 diff
(100 %id)
BG118289 adenocarcinoma, cell line, Liver .a 626 to 1339 1 to 711       711/951
(74 %)
17 diff
(98.3 %id)
CN407104 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 633 to 1227 1 to 595       595/595
(100 %)
1 diff
(99.9 %id)
CR621735 HeLa cells Cot 25-normalized .a 646 to 2346 1 to 1701       1701/1701
(100 %)
0 diff
(100 %id)
AL555946 placenta .a 646 to 1568 1 to 921   fully sequenced,   921/921
(100 %)
0 diff
(100 %id)
AA292640 germinal center B cell .a 651 to 987 1 to 336   fully sequenced,   336/336
(100 %)
1 diff
(99.8 %id)
BE894889 melanotic melanoma, skin .a 658 to 1268 1 to 611       611/611
(100 %)
0 diff
(100 %id)
CX782209 human embryonic stem cells .a 720 to 1511 1 to 792       792/792
(100 %)
1 diff
(99.9 %id)
BM478055 lymph, lymphoma, cell line .a 730 to 1740 31 to 1043       1013/1043
(97 %)
23 diff
(97.8 %id)
CB158147 Liver .a 743 to 1267 1 to 525       525/525
(100 %)
0 diff
(100 %id)
BQ684986 ductal carcinoma, cell line, Pancreas .a 744 to 1666 1 to 931       931/931
(100 %)
22 diff
(97.7 %id)
CX784044 human embryonic stem cells .a 833 to 1504 1 to 672       672/672
(100 %)
0 diff
(100 %id)
BE247726 leukopheresis .a 855 to 1172 318 to 1       318/318
(100 %)
0 diff
(100 %id)
BG031608 breast, mammary adenocarcinoma, cell line .a 873 to 1630 1 to 755       755/1003
(75 %)
24 diff
(97.7 %id)
AA292641 germinal center B cell .a 926 to 1292 367 to 1   fully sequenced,   367/367
(100 %)
0 diff
(100 %id)
F13141 brain, total brain .a 971 to 1314 1 to 344       344/344
(100 %)
0 diff
(100 %id)
F11988 brain, total brain .a 971 to 1291 1 to 321       321/321
(100 %)
1 diff
(99.7 %id)
CV028226 mixed .a 983 to 1628 1 to 646       646/649
(99 %)
7 diff
(99.0 %id)
CN407110 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1003 to 1619 1 to 617       617/617
(100 %)
1 diff
(99.9 %id)
BE892689 melanotic melanoma, skin .a 1028 to 1816 1 to 794       794/880
(90 %)
23 diff
(97.4 %id)
DA727855   .a 1028 to 1747 2 to 723   capped   722/725
(99 %)
5 diff
(99.4 %id)
EB386492 eye, optic nerve .a 1066 to 1823 1 to 757       757/762
(99 %)
4 diff
(99.5 %id)
BG283753 adenocarcinoma, cell line, Prostate .a 1141 to 1903 1 to 763       763/770
(99 %)
10 diff
(98.8 %id)
CB118627 Liver .a 1143 to 1744 1 to 602       602/602
(100 %)
0 diff
(100 %id)
BM790907 stomach .a 1164 to 1736 1 to 574       574/574
(100 %)
3 diff
(99.5 %id)
BM743931 Ascites, stomach .a 1172 to 1803 1 to 628       628/628
(100 %)
2 diff
(99.7 %id)
BM770884 Ascites, stomach .a 1172 to 1770 1 to 595       595/595
(100 %)
2 diff
(99.7 %id)
FN135596 breast carcinoma .a 1190 to 1292 1 to 103       103/103
(100 %)
0 diff
(100 %id)
BF724429 eye, Iris .a 1216 to 1729 1 to 514       514/514
(100 %)
0 diff
(100 %id)
EH333115   .a 1217 to 1289 2 to 74       73/74
(98 %)
6 diff
(91.9 %id)
CR609545 Placenta Cot 25-normalized .a 1218 to 2359 1 to 1142       1142/1142
(100 %)
0 diff
(100 %id)
AL545162 placenta, Placenta Cot 25-normalized .a 1218 to 2232 1 to 1005       1005/1046
(96 %)
17 diff
(98.4 %id)
BX364897 Placenta Cot 25-normalized .a 1218 to 2278 1 to 1049       1049/1053
(99 %)
20 diff
(98.2 %id)
BM453463 leiomyosarcoma, uterus .a 1225 to 1939 1 to 724       724/989
(73 %)
20 diff
(98.0 %id)
BG403561 bladder, transitional cell papilloma, cell line .a 1274 to 2104 1 to 821       821/924
(88 %)
27 diff
(97.1 %id)
BX364896 Placenta Cot 25-normalized .a 1330 to 2324 1006 to 21       986/1006
(98 %)
13 diff
(98.8 %id)
TI_154188948   .a 1334 to 2059 51 to 774       724/1008
(71 %)
31 diff
(97.0 %id)
AL572555 placenta, Placenta Cot 25-normalized .a 1395 to 2338 945 to 1   fully sequenced,   945/945
(100 %)
22 diff
(97.7 %id)
CN407116 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1416 to 2185 1 to 770       770/770
(100 %)
5 diff
(99.4 %id)
BM717330 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1429 to 1772 1 to 344   fully sequenced,   344/344
(100 %)
0 diff
(100 %id)
BE872280 adenocarcinoma, colon .a 1431 to 2156 1 to 738       738/1098
(67 %)
27 diff
(97.6 %id)
AL573903 placenta, Placenta Cot 25-normalized .a 1453 to 2352 910 to 11   fully sequenced,   900/910
(98 %)
7 diff
(99.3 %id)
AL577017 placenta, Placenta Cot 25-normalized .a 1453 to 2325 867 to 1   fully sequenced,   867/867
(100 %)
13 diff
(98.6 %id)
TI_149287645   .a 1473 to 2380 953 to 55   AAA   899/1144
(78 %)
24 diff
(98.0 %id)
CK821274 Pancreas, Purified pancreatic islet .a 1477 to 2053 1 to 577     Submitted on the opposite strand 577/577
(100 %)
1 diff
(99.9 %id)
CN353326 embryonic stem cells, DMSO-treated H9 cellline .a 1479 to 2086 1 to 608       608/608
(100 %)
1 diff
(99.9 %id)
AL576344 placenta, Placenta Cot 25-normalized .a 1480 to 2352 874 to 1       874/1015
(86 %)
8 diff
(99.3 %id)
AA477299 ovarian tumor, ovary .a 1484 to 2050 1 to 567       567/567
(100 %)
10 diff
(98.3 %id)
TI_57188490   .a 1488 to 2091 50 to 650       601/602
(99 %)
8 diff
(98.7 %id)
AA243785 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1493 to 1940 1 to 447       447/447
(100 %)
1 diff
(99.8 %id)
AL571824 placenta, Placenta Cot 25-normalized .a 1496 to 2325 829 to 1   fully sequenced,   829/829
(100 %)
3 diff
(99.7 %id)
TI_154128336   .a 1496 to 2382 955 to 88   AAA   870/962
(90 %)
28 diff
(97.1 %id)
TI_227715344   .a 1502 to 2383 965 to 100   AAA   868/987
(87 %)
20 diff
(98.0 %id)
TI_227714319   .a 1503 to 2375 946 to 93   AAA   856/954
(89 %)
22 diff
(97.7 %id)
TI_149289603   .a 1507 to 2388 948 to 79   AAA   870/970
(89 %)
25 diff
(97.5 %id)
AL514847 neuroblastoma, placenta .a 1521 to 2379 858 to 1       858/858
(100 %)
25 diff
(97.1 %id)
AL555945 placenta .a 1538 to 2317 804 to 28   fully sequenced,   777/804
(96 %)
4 diff
(99.6 %id)
TI_154102130   .a 1572 to 2375 888 to 94   AAA   798/944
(84 %)
14 diff
(98.6 %id)
CD365814 Alveolar Macrophage, lung .a 1599 to 2383 801 to 22   tiling clone, AAA   782/784
(99 %)
10 diff
(98.8 %id)
BY995073   .a 1604 to 2320 10 to 726       717/726
(98 %)
6 diff
(99.2 %id)
BM714602 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1607 to 2046 1 to 440   fully sequenced,   440/440
(100 %)
0 diff
(100 %id)
TI_149295276   .a 1620 to 2375 831 to 79   AAA   753/940
(80 %)
5 diff
(99.5 %id)
TI_149310972   .a 1620 to 2375 827 to 82   AAA   746/905
(82 %)
18 diff
(98.1 %id)
BQ774582 Chondrosarcoma Grade II, Left Pelvis .a 1620 to 2375 772 to 19   AAA   754/762
(98 %)
3 diff
(99.7 %id)
BU620345 Cell Line, Chondrosarcoma .a 1620 to 2380 768 to 14   AAA   755/757
(99 %)
8 diff
(99.0 %id)
BQ009678 Chondrosarcoma, Left Pubic Bone .a 1625 to 2380 764 to 14   AAA   751/755
(99 %)
5 diff
(99.4 %id)
BM985292 lung .a 1625 to 2375 767 to 19   AAA   749/749
(100 %)
2 diff
(99.8 %id)
BQ575629 Chondrosarcoma Grade II, Left Pelvis .a 1625 to 2380 769 to 19   AAA   751/755
(99 %)
5 diff
(99.4 %id)
CB528878 Aveolar Macrophage, lung .a 1625 to 2380 764 to 14   AAA   751/751
(100 %)
6 diff
(99.3 %id)
CD365022 Alveolar Macrophage, lung .a 1625 to 2375 764 to 19   AAA   746/746
(100 %)
6 diff
(99.2 %id)
AI140757 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1628 to 2375 758 to 11   AAA   748/748
(100 %)
9 diff
(98.8 %id)
CA445372 Chondrosarcoma, Left Pubic Bone .a 1686 to 2375 708 to 19   AAA   690/690
(100 %)
0 diff
(100 %id)
BX330381 Placenta Cot 25-normalized .a 1692 to 2378 693 to 1       693/707
(98 %)
30 diff
(95.8 %id)
BX456057 T cells (Jurkat cell line) .a 1698 to 2368 676 to 4       673/887
(75 %)
9 diff
(99.0 %id)
BU739143 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1742 to 2375 651 to 19   fully sequenced, AAA   633/633
(100 %)
0 diff
(100 %id)
BJ990927 hepatoblastoma .a 1821 to 2360 540 to 1       540/540
(100 %)
0 diff
(100 %id)
DB356466 whole embryo, mainly head .a 1827 to 2375 548 to 1       548/594
(92 %)
2 diff
(99.7 %id)
DB325082   .a 1829 to 2375 547 to 1       547/547
(100 %)
0 diff
(100 %id)
BM675365 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2016 to 2380 383 to 19   fully sequenced, AAA   365/365
(100 %)
0 diff
(100 %id)
F10744 brain, total brain .a 2091 to 2375 285 to 1       285/285
(100 %)
1 diff
(99.7 %id)
F09635 brain, total brain .a 2104 to 2375 272 to 1       272/272
(100 %)
0 diff
(100 %id)
AA243770 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2254 to 2379 128 to 3       126/128
(98 %)
0 diff
(100 %id)
AA477300 ovarian tumor, ovary .a 2282 to 2375 94 to 1       94/94
(100 %)
0 diff
(100 %id)
DC413327 liver, tumor tissue .b 1 to 570 5 to 574   tiling clone,   574/574
(100 %)
0 diff
(100 %id)
NM_201224.1   .b 393 to 2056 1 to 1664 exact RefSeq, AAA   1664/1664
(100 %)
0 diff
(100 %id)
CT002665 T-Lymphocytes .b 424 to 1304 1 to 887   tiling clone,   887/902
(98 %)
9 diff
(99.1 %id)
AF078843 Liver .b 436 to 2056 1 to 1621   tiling clone, AAA   1621/1621
(100 %)
1 diff
(100.0 %id)
C75328   .b 1001 to 1498 1 to 503       503/512
(98 %)
15 diff
(97.1 %id)
AA169151   .b 1501 to 1942 1 to 443     Submitted on the opposite strand 443/443
(100 %)
2 diff
(99.6 %id)
TI_149302058   .b 1503 to 2056 651 to 98   AAA   554/799
(69 %)
4 diff
(99.5 %id)
CA430679 cell lines, Chondrosarcoma .b 1505 to 2056 572 to 19   AAA   554/554
(100 %)
5 diff
(99.1 %id)
BI489534 brain .b 1512 to 1999 522 to 17       506/558
(90 %)
0 diff
(100 %id)
TI_45379334   .b 1512 to 1999 522 to 17       506/558
(90 %)
0 diff
(100 %id)
AA525954 normal prostate, Prostate .b 1518 to 2064 539 to 1       539/540
(99 %)
27 diff
(95.0 %id)
T58970 ovary .b 1523 to 1938 1 to 424   fully sequenced,   424/424
(100 %)
9 diff
(97.9 %id)
BF476218 Prostate .b 1523 to 2064 542 to 1       542/552
(98 %)
14 diff
(97.5 %id)
AA926776 pooled germ cell tumors .b 1528 to 2061 546 to 13   AAA   534/534
(100 %)
0 diff
(100 %id)
AI375403 brain, glioblastoma (pooled) .b 1533 to 2061 529 to 1       529/529
(100 %)
0 diff
(100 %id)
BE710922 head_neck .b 1536 to 1873 363 to 24       340/377
(90 %)
0 diff
(100 %id)
AI963246 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1540 to 2062 523 to 1       523/523
(100 %)
0 diff
(100 %id)
AI887623 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 1541 to 2061 522 to 1       522/522
(100 %)
1 diff
(99.9 %id)
AA720667 germinal center B-cells, tonsil .b 1542 to 2060 523 to 5       519/523
(99 %)
0 diff
(100 %id)
N51420 multiple sclerosis lesions .b 1554 to 2061 512 to 1       512/512
(100 %)
6 diff
(98.9 %id)
AW795718 uterus .b 1556 to 1823 277 to 9       269/277
(97 %)
0 diff
(100 %id)
BE698002 colon .b 1556 to 2035 497 to 20       478/498
(95 %)
0 diff
(100 %id)
BE774701 uterus .b 1556 to 1802 250 to 3       248/250
(99 %)
0 diff
(100 %id)
AA456683 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1557 to 1799 1 to 243   fully sequenced,   243/243
(100 %)
1 diff
(99.6 %id)
BU620892 Cell Line, Chondrosarcoma .b 1558 to 2061 517 to 14   AAA   504/504
(100 %)
0 diff
(100 %id)
CD364441 Alveolar Macrophage, lung .b 1558 to 2064 528 to 22   AAA   507/507
(100 %)
4 diff
(99.3 %id)
BP383995 pancreatic islet .b 1564 to 2060 1 to 497     Submitted on the opposite strand 497/499
(99 %)
1 diff
(99.8 %id)
AI935079 pooled .b 1568 to 2060 493 to 5       489/493
(99 %)
0 diff
(100 %id)
AI923007 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1570 to 2056 490 to 4       487/490
(99 %)
0 diff
(100 %id)
BE439510 Trabecular meshwork .b 1573 to 2061 517 to 29   AAA   489/493
(99 %)
3 diff
(99.4 %id)
AA926662 pooled .b 1575 to 2062 490 to 3       488/490
(99 %)
0 diff
(100 %id)
DB528166 testis .b 1579 to 2061 1 to 483     Submitted on the opposite strand 483/483
(100 %)
0 diff
(100 %id)
AA643869 normal prostate, Prostate .b 1589 to 2062 475 to 2       474/475
(99 %)
0 diff
(100 %id)
BE183596 head_neck .b 1592 to 1935 7 to 348       342/348
(98 %)
6 diff
(98.3 %id)
AI565563 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 1593 to 2059 467 to 1       467/467
(100 %)
0 diff
(100 %id)
AI635031 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1593 to 2056 464 to 1       464/464
(100 %)
0 diff
(100 %id)
R49082.
matches multiple genes
whole brain .b 1594 to 2061 498 to 11   AAA also hits gene NDFIP2 488/489
(99 %)
31 diff
(93.7 %id)
AA568784 colon, colon tumor RER+ .b 1597 to 2060 464 to 1       464/464
(100 %)
0 diff
(100 %id)
AI371080 brain, glioblastoma (pooled) .b 1600 to 2056 457 to 1       457/457
(100 %)
0 diff
(100 %id)
AI422036 brain, glioblastoma (pooled) .b 1600 to 2056 457 to 1       457/457
(100 %)
1 diff
(99.8 %id)
TI_154105059   .b 1600 to 2061 547 to 87   AAA   461/709
(65 %)
0 diff
(100 %id)
CA446347 Chondrosarcoma, Left Pubic Bone .b 1600 to 2061 474 to 14   AAA   461/688
(67 %)
0 diff
(100 %id)
DB516469 testis .b 1603 to 2061 1 to 459     Submitted on the opposite strand 459/459
(100 %)
1 diff
(99.8 %id)
AA169774   .b 1604 to 2041 445 to 1     Submitted on the opposite strand 445/445
(100 %)
13 diff
(97.1 %id)
AW273482 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 1604 to 2056 453 to 1       453/453
(100 %)
0 diff
(100 %id)
AI338321 lung .b 1605 to 2062 458 to 1       458/458
(100 %)
0 diff
(100 %id)
AW014508   .b 1606 to 2061 473 to 18   AAA   456/456
(100 %)
2 diff
(99.6 %id)
AI039285   .b 1608 to 2062 459 to 5       455/459
(99 %)
0 diff
(100 %id)
AI686356 Prostate .b 1608 to 2062 456 to 2       455/456
(99 %)
0 diff
(100 %id)
AA405735.
matches multiple genes
  .b 1617 to 2068 453 to 2     also hits gene CALCOCO2 452/453
(99 %)
0 diff
(100 %id)
AA609015   .b 1618 to 2059 442 to 1       442/442
(100 %)
0 diff
(100 %id)
BF884970 testis_normal .b 1619 to 1828 1 to 205       205/205
(100 %)
11 diff
(94.7 %id)
AI040165   .b 1619 to 2062 447 to 5       443/447
(99 %)
0 diff
(100 %id)
AW235934 Kidney .b 1619 to 2062 452 to 6       447/452
(98 %)
0 diff
(100 %id)
AI969562 malignant melanoma, metastatic to lymphnode, skin .b 1620 to 2056 437 to 1       437/437
(100 %)
1 diff
(99.8 %id)
AW008723 brain, glioblastoma (pooled) .b 1628 to 2056 429 to 1       429/429
(100 %)
0 diff
(100 %id)
AI811926 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 1635 to 2060 429 to 5       425/429
(99 %)
0 diff
(100 %id)
AI969559 malignant melanoma, metastatic to lymphnode, skin .b 1640 to 2060 425 to 5       421/425
(99 %)
0 diff
(100 %id)
AI090976 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1642 to 2058 417 to 1       417/417
(100 %)
0 diff
(100 %id)
AI049650   .b 1642 to 2058 417 to 1       417/417
(100 %)
0 diff
(100 %id)
AI695834 Prostate .b 1645 to 2056 411 to 1       411/411
(100 %)
1 diff
(99.8 %id)
AI521358 adenocarcinoma, Pancreas .b 1647 to 2061 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AI817879 colon, colon tumor, RER+ .b 1651 to 2059 409 to 1       409/409
(100 %)
0 diff
(100 %id)
AA635940 invasive tumor (cell line), Prostate .b 1652 to 2055 404 to 1       404/404
(100 %)
0 diff
(100 %id)
AI187249 lung .b 1655 to 2060 411 to 6       406/411
(98 %)
0 diff
(100 %id)
AA310493   .b 1659 to 2056 400 to 1     Submitted on the opposite strand 400/400
(100 %)
2 diff
(99.5 %id)
AA548897 normal prostate, Prostate .b 1661 to 2061 422 to 22   AAA   401/401
(100 %)
0 diff
(100 %id)
C06441   .b 1671 to 2060 398 to 5       394/402
(98 %)
0 diff
(100 %id)
BM980322 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 1671 to 2056 404 to 19   AAA   386/386
(100 %)
0 diff
(100 %id)
AI251917 brain, tumor, 5 pooled (see description) .b 1674 to 2056 409 to 27   AAA   383/383
(100 %)
0 diff
(100 %id)
BQ425234 eye, retinoblastoma .b 1684 to 2061 1 to 378   AAA   378/378
(100 %)
0 diff
(100 %id)
AV735724 cord Blood .b 1685 to 2056 1 to 358   AAA   358/358
(100 %)
15 diff
(95.9 %id)
AI961668 adenocarcinoma, Pancreas .b 1703 to 2062 362 to 3       360/362
(99 %)
0 diff
(100 %id)
AI493342 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1706 to 2060 357 to 3       355/357
(99 %)
0 diff
(100 %id)
C02193   .b 1707 to 2035 1 to 334       334/337
(99 %)
6 diff
(98.3 %id)
AA443198.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1716 to 2058 343 to 1     Submitted on the opposite strand, also hits gene vorspobu 343/343
(100 %)
2 diff
(99.5 %id)
T23518   .b 1718 to 2059 347 to 1       347/349
(99 %)
5 diff
(98.6 %id)
AW078604 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .b 1724 to 2062 340 to 2       339/340
(99 %)
0 diff
(100 %id)
AA829408 germinal center B cell .b 1730 to 2068 341 to 3       339/341
(99 %)
0 diff
(100 %id)
T30575 lung .b 1739 to 1987 250 to 1     Submitted on the opposite strand 250/250
(100 %)
3 diff
(98.8 %id)
BE242388 leukopheresis .b 1743 to 2056 314 to 1       314/314
(100 %)
1 diff
(99.7 %id)
AA502312 colon .b 1751 to 2059 309 to 1       309/309
(100 %)
2 diff
(99.4 %id)
AA456285 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1769 to 2058 290 to 1   fully sequenced,   290/290
(100 %)
1 diff
(99.7 %id)
AA581169 ovary, ovary bulk tumor .b 1775 to 2065 291 to 1   tiling clone,   291/291
(100 %)
0 diff
(100 %id)
AI933536 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1776 to 2062 282 to 1       282/283
(99 %)
7 diff
(97.6 %id)
FN055725 breast carcinoma .b 1779 to 1830 52 to 1     Submitted on the opposite strand 52/52
(100 %)
0 diff
(100 %id)
CD559741 mixed .b 1812 to 1899 9 to 96     Submitted on the opposite strand 88/102
(86 %)
2 diff
(98.1 %id)
BX342738   .b 1816 to 2062 1 to 246       246/246
(100 %)
1 diff
(99.6 %id)
AA455359 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1826 to 2054 229 to 1       229/229
(100 %)
1 diff
(99.6 %id)
AW273701 lung, two pooled squamous cell carcinomas .b 1840 to 2062 223 to 1       223/223
(100 %)
0 diff
(100 %id)
FN102154 breast carcinoma .b 1873 to 1954 84 to 1     Submitted on the opposite strand 84/84
(100 %)
2 diff
(97.7 %id)
FN176549 breast carcinoma .b 1903 to 2006 1 to 98       98/98
(100 %)
5 diff
(94.9 %id)
EC504967 Prostate .b 1905 to 2006 1 to 103       103/103
(100 %)
4 diff
(96.2 %id)
T57617 ovary .b 1908 to 2069 171 to 12   fully sequenced,   160/171
(93 %)
5 diff
(97.1 %id)
AA909558 pooled .b 1913 to 2061 149 to 1       149/149
(100 %)
0 diff
(100 %id)
AK310501 testis .c 1 to 1517 1 to 1517 G60R A131T tiling clone,   1517/1517
(100 %)
3 diff
(99.9 %id)
NM_001130415.1   .d 1 to 4731 5 to 4735 exact RefSeq, AAA   4735/4735
(100 %)
0 diff
(100 %id)
DA753433   .d 1 to 215 2 to 216   tiling clone, capped   215/215
(100 %)
0 diff
(100 %id)
DR000985 fetal brain .d 6 to 714 1 to 709       709/709
(100 %)
4 diff
(99.5 %id)
BC042478 Eye, retinoblastoma .d 11 to 4647 1 to 4632 exact tiling clone, available from MGC, AAA   4632/4632
(100 %)
6 diff
(99.9 %id)
BE783930 eye, retinoblastoma .d 32 to 775 1 to 747   available from MGC,   747/747
(100 %)
39 diff
(94.8 %id)
BU172495 melanotic melanoma, skin .d 169 to 811 5 to 651       647/905
(71 %)
17 diff
(98.2 %id)
AL543236 placenta, Placenta Cot 25-normalized .d 176 to 1084 1 to 907       907/973
(93 %)
16 diff
(98.4 %id)
BQ425973 leiomyosarcoma, uterus .d 189 to 1068 40 to 923       884/924
(95 %)
13 diff
(98.6 %id)
TI_1520872111   .d 202 to 1346 1205 to 63     Submitted on the opposite strand 1143/1309
(87 %)
0 diff
(100 %id)
DB454377 testis .d 321 to 777 1 to 456       456/456
(100 %)
3 diff
(99.4 %id)
DB228816 trachea .d 334 to 903 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BI603678 brain, hypothalamus .d 359 to 991 6 to 638       633/638
(99 %)
6 diff
(99.1 %id)
TI_45215437   .d 359 to 991 87 to 719       633/719
(88 %)
6 diff
(99.2 %id)
DB218493 trachea .d 366 to 924 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB443271 testis .d 461 to 907 1 to 447       447/447
(100 %)
5 diff
(98.9 %id)
BQ073685 epidermoid carcinoma, cell line, lung .d 522 to 1239 1 to 724       724/1098
(65 %)
9 diff
(99.2 %id)
BU527186 epidermoid carcinoma, cell line, lung .d 522 to 1168 1 to 654       654/772
(84 %)
7 diff
(99.1 %id)
BU527834 epidermoid carcinoma, cell line, lung .d 522 to 1107 1 to 594       594/845
(70 %)
12 diff
(98.6 %id)
BU529085 epidermoid carcinoma, cell line, lung .d 522 to 1168 1 to 648       648/798
(81 %)
8 diff
(99.0 %id)
AA458676   .d 646 to 876 1 to 228     Submitted on the opposite strand 228/228
(100 %)
3 diff
(98.7 %id)
BX501788 Liver .d 753 to 1135 8 to 390       383/390
(98 %)
6 diff
(98.5 %id)
CD358748 testis .d 906 to 1334 459 to 29     Submitted on the opposite strand 431/1100
(39 %)
9 diff
(99.2 %id)
AL599736   .d 947 to 1529 11 to 594       584/594
(98 %)
6 diff
(99.0 %id)
DA413425 thalamus .d 982 to 1537 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
DA405367 thalamus .d 984 to 1536 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DB218067 trachea .d 1171 to 1696 2 to 528   capped   527/527
(100 %)
2 diff
(99.7 %id)
DA239742 brain .d 1184 to 1749 2 to 568   capped   567/567
(100 %)
3 diff
(99.5 %id)
AK024963 colon .d 1198 to 4731 1 to 3529   available from FLJ, AAA   3529/3529
(100 %)
8 diff
(99.8 %id)
BX378431 Placenta Cot 25-normalized .d 1212 to 2359 1 to 1142   tiling clone,   1142/1142
(100 %)
9 diff
(99.3 %id)
DA402020 thalamus .d 1289 to 1850 2 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
DA831220 placenta .d 1418 to 2098 2 to 686   capped   685/699
(97 %)
19 diff
(97.3 %id)
H43506 brain .d 1454 to 1803 1 to 358   fully sequenced,   358/358
(100 %)
8 diff
(97.8 %id)
BF855702 prostate_normal .d 1754 to 2197 461 to 21     Submitted on the opposite strand 441/461
(95 %)
0 diff
(100 %id)
H42513 brain .d 1773 to 2045 285 to 1   fully sequenced,   285/285
(100 %)
2 diff
(99.3 %id)
BU782990 insulinoma, Pancreas .d 1804 to 2403 1 to 600     Submitted on the opposite strand 600/600
(100 %)
1 diff
(99.9 %id)
BX487640   .d 1916 to 2568 1 to 653       653/653
(100 %)
7 diff
(99.0 %id)
BQ214829 melanotic melanoma, skin .d 2083 to 2824 1 to 757       757/914
(82 %)
27 diff
(97.1 %id)
AL600886   .d 2103 to 2623 1 to 520       520/520
(100 %)
1 diff
(99.9 %id)
AW846953 colon .d 2151 to 2389 241 to 6       236/242
(97 %)
0 diff
(100 %id)
BX369130 Placenta Cot 25-normalized .d 2191 to 3085 1 to 898       898/898
(100 %)
30 diff
(96.7 %id)
BM470800 leiomyosarcoma, uterus .d 2221 to 3119 1 to 906       906/1074
(84 %)
19 diff
(98.3 %id)
BF928226 nervous_tumor .d 2309 to 2462 1 to 153       153/153
(100 %)
6 diff
(96.1 %id)
DA151919 amygdala .d 2330 to 2891 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DA833188 placenta .d 2417 to 3028 2 to 616   capped   615/622
(98 %)
15 diff
(97.6 %id)
BE891486 melanotic melanoma, skin .d 2547 to 3103 1 to 560       560/560
(100 %)
6 diff
(99.0 %id)
BX482082   .d 2569 to 3111 1 to 543       543/546
(99 %)
3 diff
(99.5 %id)
AW166189 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 2606 to 3008 425 to 23   AAA   403/403
(100 %)
12 diff
(97.1 %id)
CB999241 Pooled-Skin .d 2619 to 3019 1 to 403   tiling clone,   403/1005
(40 %)
5 diff
(99.6 %id)
AW937812 denis_drash .d 2718 to 3243 5 to 525       521/525
(99 %)
6 diff
(98.9 %id)
BQ217202 melanotic melanoma, skin .d 2728 to 3552 1 to 830       830/850
(97 %)
20 diff
(97.7 %id)
AA311360   .d 2735 to 3253 1 to 519       519/519
(100 %)
1 diff
(99.9 %id)
DA208189 brain .d 2770 to 3338 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
AL599116   .d 2789 to 3121 9 to 341       333/333
(100 %)
2 diff
(99.4 %id)
DA752762   .d 2807 to 3331 2 to 525   capped   524/524
(100 %)
3 diff
(99.5 %id)
BX477421   .d 2877 to 3328 1 to 452       452/452
(100 %)
0 diff
(100 %id)
BF671562 muscle (skeletal) .d 2879 to 3312 1 to 441       441/800
(55 %)
16 diff
(98.0 %id)
M79115   .d 2910 to 3224 315 to 1       315/315
(100 %)
1 diff
(99.7 %id)
CD512654 Pooled-Skin .d 2911 to 3544 1 to 640   tiling clone,   640/785
(81 %)
9 diff
(98.9 %id)
BE897335 melanotic melanoma, skin .d 2923 to 3441 23 to 549       527/1048
(50 %)
17 diff
(98.4 %id)
BM926489 pooled lung and spleen .d 3001 to 4023 5 to 1041       1037/1134
(91 %)
42 diff
(96.3 %id)
CR601241 Placenta Cot 25-normalized .d 3003 to 4718 1 to 1716       1716/1716
(100 %)
0 diff
(100 %id)
BX395708 Placenta Cot 25-normalized .d 3003 to 3881 1 to 880   fully sequenced,   880/880
(100 %)
2 diff
(99.8 %id)
DB059169 testis .d 3052 to 3564 2 to 514   capped   513/513
(100 %)
3 diff
(99.5 %id)
AL569935 placenta, Placenta Cot 25-normalized .d 3671 to 4691 1007 to 1       1007/1059
(95 %)
37 diff
(96.6 %id)
DB376769 placenta .d 3776 to 4358 584 to 1       584/587
(99 %)
38 diff
(93.6 %id)
BX395707 Placenta Cot 25-normalized .d 3851 to 4718 863 to 1   fully sequenced,   863/863
(100 %)
2 diff
(99.8 %id)
DB379794 placenta .d 4134 to 4731 592 to 1       592/592
(100 %)
19 diff
(96.8 %id)
TI_44172203   .e 1 to 896 119 to 1028 A124S K142R Q213P L215N Q216F ... tiling clone,   908/1117
(81 %)
39 diff
(96.6 %id)
BG287719 bladder, transitional cell papilloma, cell line .e 11 to 773 1 to 767       767/868
(88 %)
10 diff
(98.9 %id)
BG613686 embryonal carcinoma, testis .e 15 to 773 1 to 761       761/770
(98 %)
13 diff
(98.4 %id)
BG390620 embryonal carcinoma, cell line, testis .e 17 to 775 1 to 746       746/873
(85 %)
15 diff
(98.3 %id)
BQ880734 dorsal root ganglia .e 20 to 797 1 to 783 H7T D8I S9L P10R T11P ...     783/784
(99 %)
9 diff
(98.9 %id)
BU183909 melanotic melanoma, skin .e 27 to 773 16 to 763       748/878
(85 %)
9 diff
(99.0 %id)
BU171743 melanotic melanoma, skin .e 32 to 773 12 to 755       744/905
(82 %)
14 diff
(98.5 %id)
TI_45379332   .e 32 to 775 57 to 804       745/827
(90 %)
27 diff
(96.8 %id)
CR993203 T-Lymphocytes .e 32 to 773 1 to 743       743/800
(92 %)
2 diff
(99.8 %id)
AF190165 aorta .e 37 to 2361 1 to 2324   tiling clone, AAA   2324/2324
(100 %)
2 diff
(100.0 %id)
BF026582 melanotic melanoma, skin .e 37 to 773 1 to 737       737/763
(96 %)
21 diff
(97.3 %id)
BI488673 brain .e 41 to 775 1 to 740       737/763
(96 %)
21 diff
(97.3 %id)
AA233216 brain, neuroepithelial cells .e 44 to 436 1 to 392       392/392
(100 %)
3 diff
(99.3 %id)
BE542608 cervix .e 50 to 778 1 to 735       735/1033
(71 %)
38 diff
(96.4 %id)
BG035517 adenocarcinoma, cell line, Liver .e 77 to 773 1 to 694       694/978
(70 %)
18 diff
(98.2 %id)
CR623905 Placenta Cot 25-normalized .e 561 to 2327 1 to 1767   tiling clone,   1767/1767
(100 %)
0 diff
(100 %id)
N94098 liver and spleen .e 1093 to 1544 1 to 451       451/451
(100 %)
1 diff
(99.8 %id)
BQ349160 head_neck .e 1274 to 1808 574 to 42       534/574
(93 %)
7 diff
(98.8 %id)
BQ349085 head_neck .e 1298 to 1795 539 to 49       491/566
(86 %)
9 diff
(98.5 %id)
N69278 liver and spleen .e 1995 to 2362 371 to 1       371/371
(100 %)
2 diff
(99.5 %id)
AA252292 brain, neuroepithelial cells .e 2089 to 2365 281 to 5       277/281
(98 %)
0 diff
(100 %id)
AU310091 neuroblastoma .f 1 to 575 1 to 575   tiling clone,   575/575
(100 %)
0 diff
(100 %id)
DA000381   .f 8 to 514 2 to 508   capped   507/507
(100 %)
1 diff
(99.9 %id)
BX427900 fetal liver, Liver .f 18 to 950 1 to 928   tiling clone,   928/928
(100 %)
8 diff
(99.2 %id)
AA148066   .f 30 to 527 1 to 498       498/498
(100 %)
0 diff
(100 %id)
AA233524 brain, neuroepithelial cells .f 36 to 376 1 to 340       340/340
(100 %)
1 diff
(99.8 %id)
BX427899 fetal liver, Liver .f 1903 to 2850 939 to 1   tiling clone,   937/939
(99 %)
26 diff
(97.3 %id)
AA147954   .f 2323 to 2887 559 to 2   tiling clone,   558/578
(96 %)
0 diff
(100 %id)
AU310092 neuroblastoma .f 2343 to 2881 542 to 4       539/542
(99 %)
0 diff
(100 %id)
DB294924   .f 2360 to 2875 516 to 1       516/516
(100 %)
0 diff
(100 %id)
AA233452 brain, neuroepithelial cells .f 2449 to 2879 435 to 5       431/435
(99 %)
0 diff
(100 %id)
TI_1520872117   .g 1 to 1114 51 to 1154 exact tiling clone, Submitted on the opposite strand 1104/1264
(87 %)
13 diff
(99.0 %id)
TI_1520873855   .g 1 to 469 468 to 2       467/1250
(37 %)
5 diff
(99.6 %id)
TI_1520873859   .g 1 to 823 830 to 7       824/1246
(66 %)
13 diff
(99.0 %id)
TI_1520873889   .g 1 to 469 471 to 4       468/1249
(37 %)
5 diff
(99.6 %id)
BC126433 Brain, cerebellum, PCR rescued clones .g 10 to 1267 1 to 1258 exact tiling clone,   1258/1259
(99 %)
2 diff
(99.9 %id)
BC126435 Brain, cerebellum, PCR rescued clones .g 10 to 1267 1 to 1258 exact     1258/1259
(99 %)
2 diff
(99.9 %id)
NM_030817.2   .g 10 to 4652 1 to 4643 exact RefSeq, AAA   4643/4643
(100 %)
0 diff
(100 %id)
DB457403 testis .g 62 to 533 1 to 472       472/472
(100 %)
1 diff
(99.8 %id)
DB460118 testis .g 62 to 718 1 to 657       657/657
(100 %)
1 diff
(99.9 %id)
AK057867 brain .g 63 to 1599 1 to 1537 exact available from FLJ,   1537/1838
(83 %)
3 diff
(99.9 %id)
AK225176 brain .g 63 to 1426 1 to 1364 exact tiling clone,   1364/1364
(100 %)
2 diff
(99.9 %id)
DA103000 cerebellum .g 63 to 641 2 to 596   capped   547/595
(91 %)
14 diff
(97.7 %id)
DA223650 brain .g 63 to 578 2 to 518   capped   517/517
(100 %)
2 diff
(99.7 %id)
DA225762 brain .g 63 to 599 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
DA325700 hippocampus .g 63 to 681 2 to 620   capped   619/619
(100 %)
0 diff
(100 %id)
DA388673 thalamus .g 63 to 572 2 to 511   capped   510/510
(100 %)
1 diff
(99.9 %id)
DA404258 thalamus .g 63 to 366 2 to 305   capped   304/304
(100 %)
0 diff
(100 %id)
DA405004 thalamus .g 63 to 592 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
DA407227 thalamus .g 63 to 622 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA999134 breast, tumor tissue .g 63 to 534 2 to 473   capped   472/472
(100 %)
1 diff
(99.8 %id)
DB179809 kidney, tumor tissue .g 63 to 359 2 to 298   capped   297/297
(100 %)
0 diff
(100 %id)
DB230461 trachea .g 63 to 643 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DB236470 trachea .g 63 to 274 2 to 213   capped   212/212
(100 %)
0 diff
(100 %id)
DB236494 trachea .g 63 to 483 2 to 422   capped   421/421
(100 %)
2 diff
(99.6 %id)
DB283572 uterus .g 63 to 459 2 to 398   capped   397/397
(100 %)
0 diff
(100 %id)
DB292658 uterus .g 63 to 559 2 to 498   capped   497/497
(100 %)
0 diff
(100 %id)
AK314392 trachea .g 70 to 841 1 to 772 exact     772/772
(100 %)
0 diff
(100 %id)
DB222911 trachea .g 71 to 638 2 to 573   capped   572/572
(100 %)
5 diff
(99.2 %id)
AL136783 testis .g 84 to 4653 1 to 4570 G33R tiling clone, available from DKFZ, AAA   4570/4570
(100 %)
11 diff
(99.8 %id)
BU657167 blood .h 1 to 597 8 to 604 exact tiling clone,   597/604
(98 %)
6 diff
(99.1 %id)
AL833469 human cervix .i 1 to 2684 1 to 2684 exact tiling clone, available from DKFZ, AAA   2684/2684
(100 %)
4 diff
(99.9 %id)
DA284103 corpus callosum .i 10 to 507 2 to 500   tiling clone, capped   499/499
(100 %)
2 diff
(99.6 %id)
T75340 whole brain .i 225 to 573 1 to 352       352/365
(96 %)
9 diff
(97.6 %id)
AL548362 placenta, Placenta Cot 25-normalized .i 361 to 1274 1 to 916       916/981
(93 %)
8 diff
(99.2 %id)
AW663236 2 pooled high-grade transitional celltumors, genitourinary tract .i 495 to 750 1 to 257   tiling clone,   257/257
(100 %)
1 diff
(99.7 %id)
CN407109 embryonic stem cells, cell lines H1, H7, andH9 .i 543 to 1267 1 to 724       724/724
(100 %)
4 diff
(99.5 %id)
DA833899 placenta .i 579 to 1356 2 to 783   capped   782/782
(100 %)
7 diff
(99.2 %id)
CB268422 adipose .i 650 to 1118 1 to 469       469/469
(100 %)
0 diff
(100 %id)
AL572947 placenta, Placenta Cot 25-normalized .i 1789 to 2650 879 to 1       879/1094
(80 %)
29 diff
(97.4 %id)
DB380888 placenta .i 2132 to 2689 556 to 1       556/558
(99 %)
10 diff
(98.3 %id)
CB159375 Liver .j 1 to 554 1 to 554 K136X tiling clone,   554/554
(100 %)
1 diff
(99.9 %id)
TI_57180606   .k-u 1 to 414 77 to 492   tiling clone,   416/1230
(33 %)
12 diff
(99.1 %id)
BI768155 pooled lung and spleen .k-u 10 to 414 1 to 408   tiling clone,   408/1146
(35 %)
9 diff
(99.3 %id)
BQ420867 embryonal carcinoma, cell line, testis .k-u 164 to 1001 1 to 847   tiling clone,   847/940
(90 %)
11 diff
(98.9 %id)
FN107933 breast carcinoma .k-u 284 to 364 1 to 80   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 80/90
(88 %)
4 diff
(95.6 %id)
AW845276 colon .k-u 398 to 915 518 to 3       516/518
(99 %)
0 diff
(100 %id)
TI_159695878   .k-u 490 to 1332 75 to 908   tiling clone, Submitted on the opposite strand 834/1087
(76 %)
22 diff
(98.0 %id)
BF516447   .k-u 999 to 1559 578 to 18   tiling clone, AAA   561/561
(100 %)
3 diff
(99.5 %id)
DA659036   .l 1 to 560 2 to 561 Q74* tiling clone, capped   560/560
(100 %)
1 diff
(99.9 %id)
AK302536 testis .m 1 to 1044 1 to 1044 exact tiling clone,   1044/1044
(100 %)
0 diff
(100 %id)
DC400971 testis .m 1 to 548 1 to 548 exact     548/548
(100 %)
0 diff
(100 %id)
AL711470 human skeletal muscle .m 16 to 581 9 to 574 exact     566/574
(98 %)
6 diff
(99.0 %id)
DC409351 thymus .m 16 to 581 1 to 566 exact     566/566
(100 %)
0 diff
(100 %id)
BG876662 denis_drash .n 1 to 587 1 to 588   tiling clone,   588/588
(100 %)
5 diff
(99.2 %id)
BU149845 dorsal root ganglia .n 438 to 1367 26 to 956   tiling clone,   931/956
(97 %)
6 diff
(99.4 %id)
AW816469 stomach .n 1015 to 1463 43 to 492       450/509
(88 %)
8 diff
(98.5 %id)
BF448611 fibrotheoma, ovary .n 1089 to 1646 133 to 689   tiling clone, Submitted on the opposite strand 557/689
(80 %)
6 diff
(99.2 %id)
BI011091 lung_normal .n 1249 to 1755 8 to 513   tiling clone,   506/513
(98 %)
7 diff
(98.7 %id)
BE180743 head_neck .n 1534 to 1791 9 to 266       258/420
(61 %)
7 diff
(98.4 %id)
BX351882 Placenta Cot 25-normalized .n 1534 to 2220 689 to 4       686/758
(90 %)
29 diff
(96.2 %id)
BU631793 cell lines, Chondrosarcoma .n 1534 to 2228 712 to 19   AAA   694/695
(99 %)
8 diff
(98.9 %id)
CA417453 Chondrosarcoma Cell line .n 1541 to 2230 705 to 17   tiling clone, AAA   689/719
(95 %)
2 diff
(99.8 %id)
CD369782 Alveolar Macrophage, lung .n 1541 to 2223 700 to 19   AAA   682/683
(99 %)
2 diff
(99.8 %id)
BU618996 Cell Line, Chondrosarcoma .n 1543 to 2223 699 to 19   AAA   681/681
(100 %)
1 diff
(99.9 %id)
TI_227713455   .n 1551 to 2231 759 to 83   tiling clone, AAA   677/981
(69 %)
20 diff
(98.0 %id)
BQ005375 Chondrosarcoma, Left Pelvis .n 1557 to 2228 685 to 14   AAA   672/672
(100 %)
2 diff
(99.8 %id)
CK326983 placenta_normal .n 1558 to 2038 46 to 525       480/525
(91 %)
44 diff
(91.7 %id)
BQ001066 lung, Metastatic Chondrosarcoma .n 1561 to 2230 685 to 17   AAA   669/669
(100 %)
2 diff
(99.8 %id)
CA450380 Human Lung Epithelial cells, lung .n 1581 to 2223 661 to 19   AAA   643/643
(100 %)
4 diff
(99.4 %id)
BG032738 breast, mammary adenocarcinoma, cell line .n 1583 to 2226 1 to 644       644/666
(96 %)
3 diff
(99.6 %id)
AA490693 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 1585 to 2074 1 to 491       491/491
(100 %)
1 diff
(99.8 %id)
BU681741 lung .n 1585 to 2236 662 to 11   AAA   652/652
(100 %)
5 diff
(99.3 %id)
BQ771657 Chondrosarcoma Grade II, Left Pelvis .n 1586 to 2223 656 to 19   AAA   638/638
(100 %)
0 diff
(100 %id)
BU630094 cell lines, Chondrosarcoma .n 1586 to 2228 656 to 14   AAA   643/643
(100 %)
0 diff
(100 %id)
BQ953358 leiomyosarcoma, uterus .n 1588 to 2222 1 to 636       636/975
(65 %)
14 diff
(98.6 %id)
BU619015 Cell Line, Chondrosarcoma .n 1590 to 2223 652 to 19   AAA   634/634
(100 %)
0 diff
(100 %id)
AW131299 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .n 1599 to 2230 631 to 1       631/631
(100 %)
12 diff
(98.1 %id)
BM972934 lung .n 1602 to 2228 640 to 14   AAA   627/638
(98 %)
1 diff
(99.9 %id)
CA432718 cell lines, Chondrosarcoma .n 1603 to 2223 639 to 19   AAA   621/621
(100 %)
1 diff
(99.9 %id)
BU689135 lung .n 1607 to 2223 634 to 19   AAA   616/616
(100 %)
2 diff
(99.7 %id)
BM314170 Pancreas, Purified pancreatic islet .n 1629 to 2229 601 to 1       601/601
(100 %)
0 diff
(100 %id)
U25899   .n 1641 to 1981 343 to 1       343/343
(100 %)
3 diff
(99.2 %id)
BX952569   .o 1 to 629 1 to 629 exact tiling clone,   629/629
(100 %)
2 diff
(99.7 %id)
DA138018 alzheimer cortex .p-u 1 to 555 2 to 552 exact tiling clone, capped   551/551
(100 %)
3 diff
(99.5 %id)
BX378430 Placenta Cot 25-normalized .p-u 83 to 1251 1163 to 1   tiling clone,   1163/1166
(99 %)
10 diff
(99.2 %id)
BE857245 brain, glioblastoma (pooled) .p-u 174 to 653 1 to 477     Submitted on the opposite strand 477/477
(100 %)
5 diff
(99.0 %id)
BP396339 pancreatic islet .p-u 196 to 675 480 to 1   tiling clone,   480/480
(100 %)
1 diff
(99.8 %id)
AL044191 testis .p-u 292 to 693 1 to 403       403/403
(100 %)
3 diff
(99.3 %id)
CX869987 embryonic stem .p-u 297 to 940 1 to 644       644/644
(100 %)
0 diff
(100 %id)
BF988418 placenta_normal .p-u 328 to 1000 684 to 19       666/700
(95 %)
0 diff
(100 %id)
H08391 whole brain .p-u 338 to 695 1 to 366       366/503
(72 %)
14 diff
(97.3 %id)
AW861014 colon .p-u 353 to 591 1 to 237       237/252
(94 %)
5 diff
(98.1 %id)
CF456364 peripheral nervous system .p-u 456 to 1147 1 to 692       692/693
(99 %)
1 diff
(99.9 %id)
BF571321 melanotic melanoma, high MDR, skin .p-u 459 to 1084 1 to 622       622/622
(100 %)
10 diff
(98.4 %id)
BU952214 Pancreas, Purified pancreatic islet .p-u 479 to 1025 1 to 547       547/547
(100 %)
3 diff
(99.5 %id)
AA458675   .p-u 534 to 765 233 to 2     Submitted on the opposite strand 232/233
(99 %)
0 diff
(100 %id)
BX094292 multiple sclerosis lesions .p-u 539 to 1156 37 to 654   tiling clone,   618/654
(94 %)
6 diff
(99.1 %id)
N48846 multiple sclerosis lesions .p-u 539 to 776 1 to 238       238/247
(96 %)
2 diff
(99.2 %id)
BF991090 placenta_normal .p-u 541 to 833 500 to 210   AAA   291/500
(58 %)
0 diff
(100 %id)
BM693566 eye, Retina Foveal and Macular .p-u 607 to 1138 1 to 532       532/532
(100 %)
1 diff
(99.9 %id)
R30903.
matches multiple genes
placenta .p-u 615 to 926 1 to 329     also hits gene CXorf38 329/348
(94 %)
25 diff
(92.9 %id)
R26037 placenta .p-u 625 to 965 1 to 360       360/360
(100 %)
27 diff
(92.5 %id)
CF457066 peripheral nervous system .p-u 643 to 1395 20 to 774       755/778
(97 %)
5 diff
(99.4 %id)
W48596 senescent fibroblast .p-u 678 to 1128 1 to 452       452/452
(100 %)
1 diff
(99.8 %id)
BQ024715 placenta .p-u 687 to 1243 576 to 20   AAA   557/558
(99 %)
8 diff
(98.6 %id)
BP398047 pancreatic islet .p-u 729 to 1227 1 to 499     Submitted on the opposite strand 499/499
(100 %)
0 diff
(100 %id)
BM700311 eye, lens .p-u 737 to 1108 1 to 372   fully sequenced,   372/372
(100 %)
0 diff
(100 %id)
BF695912 brain, primitive neuroectoderm .p-u 788 to 1486 1 to 684       684/850
(80 %)
45 diff
(94.8 %id)
CD104031 Pooled-Skin .p-u 808 to 1593 1 to 796       796/799
(99 %)
13 diff
(98.4 %id)
AW170065 pooled .p-u 856 to 1244 392 to 4       389/392
(99 %)
0 diff
(100 %id)
AA330061   .p-u 862 to 1164 1 to 303       303/303
(100 %)
5 diff
(98.4 %id)
AI459066 carcinoid, lung .p-u 863 to 1331 1 to 469     Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
BE222229 carcinoid, lung .p-u 863 to 1344 1 to 482     Submitted on the opposite strand 482/482
(100 %)
1 diff
(99.8 %id)
AW961550   .p-u 865 to 1466 1 to 604       604/604
(100 %)
12 diff
(98.1 %id)
BG572017 placenta .p-u 885 to 1547 1 to 662       662/663
(99 %)
6 diff
(99.1 %id)
AA431105   .p-u 890 to 1257 1 to 368   fully sequenced,   368/368
(100 %)
1 diff
(99.8 %id)
BF446426 carcinoid, lung .p-u 915 to 1375 1 to 461     Submitted on the opposite strand 461/461
(100 %)
0 diff
(100 %id)
BF590168 pooled .p-u 925 to 1251 344 to 17       328/391
(83 %)
0 diff
(100 %id)
AW861214 colon .p-u 926 to 1422 21 to 515       495/515
(96 %)
6 diff
(98.9 %id)
BE696232 colon .p-u 937 to 1050 27 to 140       114/140
(81 %)
6 diff
(95.8 %id)
BE696262 colon .p-u 941 to 1475 1 to 532       532/532
(100 %)
10 diff
(98.2 %id)
BQ016522 lung, Metastatic Chondrosarcoma .p-u 948 to 1616 685 to 19   AAA   667/667
(100 %)
3 diff
(99.6 %id)
DB525557 testis .p-u 968 to 1616 1 to 648     Submitted on the opposite strand 648/648
(100 %)
3 diff
(99.6 %id)
R22466 placenta .p-u 999 to 1362 1 to 371   fully sequenced,   371/371
(100 %)
16 diff
(95.7 %id)
BU783228 insulinoma, Pancreas .p-u 1040 to 1619 588 to 9   tiling clone, Submitted on the opposite strand 580/588
(98 %)
0 diff
(100 %id)
AW861250 colon .p-u 1043 to 1600 582 to 26       557/620
(89 %)
0 diff
(100 %id)
AI816806 2 pooled tumors (clear cell type), Kidney .p-u 1049 to 1619 571 to 1       571/571
(100 %)
0 diff
(100 %id)
BM670498 eye, lens .p-u 1078 to 1613 557 to 22   fully sequenced,   536/557
(96 %)
0 diff
(100 %id)
BP395199 pancreatic islet .p-u 1079 to 1614 1 to 538     Submitted on the opposite strand 538/538
(100 %)
2 diff
(99.7 %id)
BU951952 Pancreas, Purified pancreatic islet .p-u 1108 to 1619 512 to 1       512/512
(100 %)
0 diff
(100 %id)
AI949835 2 pooled tumors (clear cell type), Kidney .p-u 1114 to 1619 508 to 3       506/508
(99 %)
0 diff
(100 %id)
BP398700 pancreatic islet .p-u 1116 to 1616 1 to 501     Submitted on the opposite strand 501/501
(100 %)
0 diff
(100 %id)
BP397465 pancreatic islet .p-u 1117 to 1616 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
BP397489 pancreatic islet .p-u 1117 to 1616 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
BP398780 pancreatic islet .p-u 1118 to 1616 1 to 500     Submitted on the opposite strand 500/500
(100 %)
1 diff
(99.8 %id)
BP397327 pancreatic islet .p-u 1119 to 1618 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
BP398537 pancreatic islet .p-u 1119 to 1616 1 to 498     Submitted on the opposite strand 498/498
(100 %)
0 diff
(100 %id)
BP397140 pancreatic islet .p-u 1120 to 1618 1 to 499     Submitted on the opposite strand 499/499
(100 %)
0 diff
(100 %id)
BP395923 pancreatic islet .p-u 1121 to 1619 1 to 499     Submitted on the opposite strand 499/500
(99 %)
1 diff
(99.8 %id)
AI760797 2 pooled tumors (clear cell type), Kidney .p-u 1127 to 1619 495 to 3       493/495
(99 %)
0 diff
(100 %id)
AA724392 parathyroid gland, parathyroid tumor .p-u 1133 to 1619 490 to 4       487/490
(99 %)
0 diff
(100 %id)
BP395877 pancreatic islet .p-u 1133 to 1602 1 to 470     Submitted on the opposite strand 470/474
(99 %)
1 diff
(99.8 %id)
AW236715 Kidney .p-u 1133 to 1616 483 to 1       483/488
(98 %)
7 diff
(98.6 %id)
AW466924 2 pooled tumors (clear cell type), Kidney .p-u 1136 to 1610 484 to 10       475/484
(98 %)
0 diff
(100 %id)
AI421673 brain, glioblastoma (pooled) .p-u 1138 to 1618 481 to 1       481/481
(100 %)
0 diff
(100 %id)
AI275614 placenta .p-u 1151 to 1616 477 to 12   AAA   466/466
(100 %)
0 diff
(100 %id)
AI334398 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .p-u 1151 to 1616 466 to 1       466/466
(100 %)
0 diff
(100 %id)
DB522878 testis .p-u 1153 to 1616 1 to 464     Submitted on the opposite strand 464/464
(100 %)
0 diff
(100 %id)
BF001998 colon, colon tumor, RER+ .p-u 1156 to 1615 460 to 1       460/460
(100 %)
0 diff
(100 %id)
AI769710 2 pooled tumors (clear cell type), Kidney .p-u 1159 to 1619 464 to 4       461/464
(99 %)
0 diff
(100 %id)
AW418862 2 pooled tumors (clear cell type), Kidney .p-u 1164 to 1619 456 to 1       456/456
(100 %)
0 diff
(100 %id)
AI127680 uterus .p-u 1177 to 1616 440 to 1       440/440
(100 %)
1 diff
(99.8 %id)
AI376732   .p-u 1177 to 1619 445 to 2       444/445
(99 %)
0 diff
(100 %id)
AI632908 carcinoid, lung .p-u 1179 to 1617 440 to 1       440/440
(100 %)
8 diff
(98.2 %id)
BE045322 carcinoid, lung .p-u 1179 to 1617 440 to 1       440/440
(100 %)
6 diff
(98.7 %id)
BE502784 carcinoid, lung .p-u 1179 to 1617 439 to 1       439/439
(100 %)
0 diff
(100 %id)
BF110386 carcinoid, lung .p-u 1180 to 1619 443 to 3       441/443
(99 %)
0 diff
(100 %id)
BF110181 carcinoid, lung .p-u 1180 to 1619 443 to 3       441/443
(99 %)
0 diff
(100 %id)
BF110191 carcinoid, lung .p-u 1180 to 1619 443 to 3       441/443
(99 %)
0 diff
(100 %id)
AW079670 esophagus, squamous cell carcinoma .p-u 1181 to 1616 452 to 14   AAA   439/439
(100 %)
3 diff
(99.4 %id)
DB519812 testis .p-u 1182 to 1616 1 to 435     Submitted on the opposite strand 435/435
(100 %)
0 diff
(100 %id)
H43249 breast .p-u 1183 to 1614 1 to 446       446/450
(99 %)
16 diff
(96.5 %id)
AI559661 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .p-u 1194 to 1616 433 to 11   AAA   423/423
(100 %)
0 diff
(100 %id)
W48597 senescent fibroblast .p-u 1197 to 1616 422 to 1       422/422
(100 %)
4 diff
(99.1 %id)
DB508159 testis .p-u 1200 to 1614 1 to 415     Submitted on the opposite strand 415/417
(99 %)
1 diff
(99.8 %id)
AI278021 placenta .p-u 1219 to 1616 415 to 18   AAA   398/398
(100 %)
2 diff
(99.5 %id)
AW275150 lung, two pooled squamous cell carcinomas .p-u 1219 to 1619 405 to 5       401/405
(99 %)
0 diff
(100 %id)
CR606352 Neuroblastoma Cot 25-normalized .p-u 1223 to 1619 1 to 397       397/397
(100 %)
0 diff
(100 %id)
BX331904 Neuroblastoma Cot 25-normalized .p-u 1223 to 1619 1 to 397   fully sequenced,   397/397
(100 %)
1 diff
(99.8 %id)
N46341 multiple sclerosis lesions .p-u 1224 to 1617 400 to 1       400/402
(99 %)
8 diff
(98.1 %id)
AA972203 pooled .p-u 1228 to 1616 389 to 1       389/389
(100 %)
1 diff
(99.8 %id)
BP396630 pancreatic islet .p-u 1241 to 1481 1 to 243     Submitted on the opposite strand 243/243
(100 %)
4 diff
(98.4 %id)
AW135526   .p-u 1241 to 1616 393 to 18   AAA   376/376
(100 %)
2 diff
(99.5 %id)
AI818309 adenocarcinoma, Pancreas .p-u 1242 to 1620 397 to 19   tiling clone, AAA   379/379
(100 %)
1 diff
(99.8 %id)
BM991596 Bone, Subchondral Bone .p-u 1243 to 1616 392 to 19   AAA   374/374
(100 %)
4 diff
(99.0 %id)
BP398261 pancreatic islet .p-u 1244 to 1616 127 to 500     Submitted on the opposite strand 374/500
(74 %)
6 diff
(98.8 %id)
AW612776 carcinoid, lung .p-u 1247 to 1617 373 to 1       373/373
(100 %)
8 diff
(97.9 %id)
AA432292   .p-u 1252 to 1619 367 to 1   fully sequenced,   367/367
(100 %)
1 diff
(99.8 %id)
AI688332 colon .p-u 1268 to 1618 351 to 1       351/351
(100 %)
0 diff
(100 %id)
AI891154 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .p-u 1269 to 1616 363 to 16   AAA   348/348
(100 %)
1 diff
(99.8 %id)
R26835 placenta .p-u 1274 to 1616 357 to 1       357/388
(92 %)
18 diff
(95.4 %id)
AI915906 Kidney .p-u 1276 to 1616 341 to 1       341/341
(100 %)
0 diff
(100 %id)
BU754349 placenta .p-u 1281 to 1616 354 to 19   AAA   336/347
(96 %)
0 diff
(100 %id)
AI282118 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .p-u 1283 to 1619 337 to 1       337/337
(100 %)
0 diff
(100 %id)
AW339013 adenocarcinoma, Pancreas .p-u 1288 to 1619 332 to 1       332/332
(100 %)
0 diff
(100 %id)
AI955500 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .p-u 1291 to 1616 325 to 1       325/325
(100 %)
1 diff
(99.7 %id)
BP396852 pancreatic islet .p-u 1309 to 1619 1 to 311     Submitted on the opposite strand 311/315
(98 %)
1 diff
(99.7 %id)
R22417 placenta .p-u 1341 to 1618 280 to 1   fully sequenced,   280/280
(100 %)
4 diff
(98.6 %id)
AI371493 brain, glioblastoma (pooled) .p-u 1350 to 1618 270 to 1       270/270
(100 %)
1 diff
(99.7 %id)
AI371495 brain, glioblastoma (pooled) .p-u 1356 to 1618 263 to 1       263/263
(100 %)
0 diff
(100 %id)
BX331903 Neuroblastoma Cot 25-normalized .p-u 1384 to 1604 222 to 1   fully sequenced,   222/222
(100 %)
3 diff
(98.7 %id)
BP395526 pancreatic islet .p-u 1410 to 1619 1 to 211     Submitted on the opposite strand 211/214
(98 %)
2 diff
(99.1 %id)
AI580680 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .p-u 1515 to 1616 129 to 28   AAA   102/102
(100 %)
1 diff
(99.1 %id)
DA223477 brain .q 1 to 589 2 to 590 exact tiling clone, capped   589/589
(100 %)
0 diff
(100 %id)
DB236451 trachea .q 1 to 479 2 to 480   capped   479/479
(100 %)
1 diff
(99.8 %id)
DA472318   .r -9 to 341 2 to 353 D8* tiling clone, capped   352/352
(100 %)
1 diff
(99.8 %id)
DA044741 bladder .r 3 to 515 2 to 514 exact tiling clone, capped   518/518
(100 %)
2 diff
(99.7 %id)
BE244821 leukopheresis .s-u 1 to 477 19 to 495 P2A C41X tiling clone,   477/495
(96 %)
6 diff
(98.8 %id)
BE243912 leukopheresis .s-u 7 to 414 1 to 408       408/408
(100 %)
1 diff
(99.8 %id)
BE245012 leukopheresis .s-u 7 to 476 1 to 470   tiling clone,   470/470
(100 %)
7 diff
(98.6 %id)
BE246836 leukopheresis .s-u 7 to 128 1 to 122       122/122
(100 %)
4 diff
(96.8 %id)
DB149227 thymus .t 1 to 464 2 to 465 exact tiling clone, capped   464/464
(100 %)
3 diff
(99.4 %id)
BF804736 colon_ins .u-u -9 to 397 1 to 407 G92S tiling clone,   407/407
(100 %)
4 diff
(99.1 %id)
AI440281 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .va-u 1 to 340 341 to 2 R67Q tiling clone,   340/341
(99 %)
0 diff
(100 %id)
129 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l, .m, .n, .o, .p-u, .q, .r, .s-u, .t, .u-u, .va-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI